Advanced search
Publication Cover
International Journal of Hyperthermia Volume 40, 2023 - Issue 1
Submit an article Journal homepage
753
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the timing and safety of hysteroscopic myomectomy of large submucosal fibroids pretreated by high intensity focused ultrasound

Kaiyin Qua Chongqing Haifu Hospital, Chongqing, ChinaView further author information
,
Min Zoua Chongqing Haifu Hospital, Chongqing, ChinaView further author information
,
Zhi Wanga Chongqing Haifu Hospital, Chongqing, ChinaView further author information
,
Chunmei Gonga Chongqing Haifu Hospital, Chongqing, ChinaView further author information
,
Yu Xionga Chongqing Haifu Hospital, Chongqing, ChinaCorrespondence[email protected]
View further author information
&
Lian Zhangb State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected]
View further author information
Article: 2249275 | Received 18 May 2023, Accepted 12 Aug 2023, Published online: 22 Aug 2023

References

  • Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine myomas: a review. Int J Fertil Steril. 2016;9:424–435.
  • Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14(2):101–119. doi: 10.1093/humupd/dmm041.
  • Salazar CA, Isaacson KB. Office operative hysteroscopy: an update. J Minim Invasive Gynecol. 2018;25(2):199–208. doi: 10.1016/j.jmig.2017.08.009.
  • Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int. 2017;2017:6848250. doi: 10.1155/2017/6848250.
  • Bhave Chittawar P, Franik S, Pouwer AW, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;10:CD004638.
  • Lagana AS, Alonso Pacheco L, Tinelli A, et al. Management of asymptomatic submucous myomas in women of reproductive age: a consensus statement from the global congress on hysteroscopy scientific committee. J Minim Invasive Gynecol. 2019;26(3):381–383. doi: 10.1016/j.jmig.2018.06.020.
  • Liao P, Jiang J, Zeng Y, et al. Comparison of outcomes of hysteroscopic myomectomy of type 2 submucous fibroids greater than 4 cm in diameter via pretreatment with HIFU or GnRH-a. Int J Hyperthermia. 2021;38(1):183–188. doi: 10.1080/02656736.2021.1874546.
  • Camanni M, Bonino L, Delpiano EM, et al. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol. 2010;17(1):59–65. doi: 10.1016/j.jmig.2009.10.013.
  • Lima MPJS, Costa-Paiva L, Brito LGO, et al. Factors associated with the complications of hysteroscopic myomectomy. Rev Bras Ginecol Obstet. 2020;42(8):476–485. doi: 10.1055/s-0040-1713915.
  • Mazzon I, Favilli A, Grasso M, et al. Risk factors for the completion of the cold loop hysteroscopic myomectomy in a One-Step procedure: a post hoc analysis. Biomed Res Int. 2018;2018:8429047. doi: 10.1155/2018/8429047.
  • Muzii L, Boni T, Bellati F, et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study. Fertil Steril. 2010;94(4):1496–1499. doi: 10.1016/j.fertnstert.2009.05.070.
  • Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev. 2017;11(11):CD000547.
  • Mavrelos D, Ben-Nagi J, Davies A, et al. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod. 2010;25(9):2264–2269. doi: 10.1093/humrep/deq188.
  • Bizzarri N, Ghirardi V, Remorgida V, et al. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. Eur J Obstet Gynecol Reprod Biol. 2015;192:22–26. doi: 10.1016/j.ejogrb.2015.06.018.
  • Osuga Y, Enya K, Kudou K, et al. Oral Gonadotropin-Releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2019;133(3):423–433.
  • Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676. doi: 10.1016/j.ultsonch.2015.05.031.
  • Zhang R, Wu W, Zou Q, et al. Comparison of clinical outcomes and postoperative quality of life after surgical treatment of type II submucous myoma via laparoscopy or hysteroscopy. J Int Med Res. 2019;47(9):4126–4133. doi: 10.1177/0300060519858027.
  • Di Lieto A, De Falco M, Pollio F, et al. Clinical response, voscular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig. 2005;12(2):123–128. doi: 10.1016/j.jsgi.2004.10.008.
  • Di Lieto A, De Falco M, Mansueto G, et al. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids:evaluation of the clinical response, the immunohistochemical expression of PDGF.bFGF and VEGF and the vascular pattern. Steroids. 2005;70(2):95–102. doi: 10.1016/j.steroids.2004.10.008.
  • Palomba S, Orio F, Jr, Russo T, et al. Long -term effectiveness and safety of GnRH agonist plus raloxirene administration in women with uterine leiomyomas. Hum Reprod. 2004;19(6):1308–1314. doi: 10.1093/humrep/deh296.
  • Lee JS, Hong GY, Lee KH, et al. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med Biol. 2019;45(12):3214–3221. doi: 10.1016/j.ultrasmedbio.2019.08.022.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.